tiprankstipranks
Advertisement
Advertisement

AU:1AD Stock Latest News

AdAlta targets sophisticated investors with speculative ASX-listed options offer
Company AnnouncementsAdAlta targets sophisticated investors with speculative ASX-listed options offer
9d ago
1AD
AdAlta files prospectus for options linked to A$2.5m placement to fund solid cancer immunotherapy push
PremiumCompany Announcements
AdAlta files prospectus for options linked to A$2.5m placement to fund solid cancer immunotherapy push
9d ago
1AD
AdAlta hires cell therapy specialists to steer FDA path for mesothelioma CAR-T
PremiumCompany Announcements
AdAlta hires cell therapy specialists to steer FDA path for mesothelioma CAR-T
9d ago
1AD
AdAlta Showcases BZDS1901 CAR-T as Emerging Hope for Mesothelioma
PremiumCompany Announcements
AdAlta Showcases BZDS1901 CAR-T as Emerging Hope for Mesothelioma
23d ago
1AD
AdAlta to Showcase Promising Mesothelioma CAR-T Data in Investor Webinar
PremiumCompany Announcements
AdAlta to Showcase Promising Mesothelioma CAR-T Data in Investor Webinar
27d ago
1AD
AdAlta plans major share and option issue to expand capital base
PremiumCompany AnnouncementsAdAlta plans major share and option issue to expand capital base
1M ago
1AD
AdAlta shares placed in trading halt ahead of capital raising announcement
Premium
Company Announcements
AdAlta shares placed in trading halt ahead of capital raising announcement
1M ago
1AD
AdAlta launches “East-to-West” CAR-T strategy with promising mesothelioma data
Premium
Company Announcements
AdAlta launches “East-to-West” CAR-T strategy with promising mesothelioma data
1M ago
1AD
AdAlta moves BZDS1901 CAR‑T manufacturing to Australia after promising mesothelioma data
PremiumCompany Announcements
AdAlta moves BZDS1901 CAR‑T manufacturing to Australia after promising mesothelioma data
1M ago
1AD
AdAlta taps Oribiotech’s automated platform to scale CAR-T manufacturing in Asia-Pacific
PremiumCompany Announcements
AdAlta taps Oribiotech’s automated platform to scale CAR-T manufacturing in Asia-Pacific
1M ago
1AD
AdAlta reshapes board as it pushes East-to-West CAR-T strategy
PremiumCompany Announcements
AdAlta reshapes board as it pushes East-to-West CAR-T strategy
2M ago
1AD
AdAlta Options Lapse, Trimming Potential Dilution
PremiumCompany Announcements
AdAlta Options Lapse, Trimming Potential Dilution
2M ago
1AD
AdAlta’s CAR-T therapy delivers strong tumour responses in advanced mesothelioma trial
PremiumCompany AnnouncementsAdAlta’s CAR-T therapy delivers strong tumour responses in advanced mesothelioma trial
2M ago
1AD
AdAlta secures Canadian patent to complete global AD-214 protection
Premium
Company Announcements
AdAlta secures Canadian patent to complete global AD-214 protection
3M ago
1AD
AdAlta adds investor relations specialist Fadi Diab to board as it advances East-to-West immunotherapy strategy
Premium
Company Announcements
AdAlta adds investor relations specialist Fadi Diab to board as it advances East-to-West immunotherapy strategy
3M ago
1AD
AdAlta Appoints Fadi Diab as Director with No Initial Shareholding
PremiumCompany Announcements
AdAlta Appoints Fadi Diab as Director with No Initial Shareholding
3M ago
1AD
AdAlta’s AdCella Bolsters Advisory Board to Advance Armoured CAR-T Therapy BZDS1901
PremiumCompany Announcements
AdAlta’s AdCella Bolsters Advisory Board to Advance Armoured CAR-T Therapy BZDS1901
3M ago
1AD
AdAlta outlines ‘East to West’ strategy to expand CAR-T access across Australia and SE Asia
PremiumCompany Announcements
AdAlta outlines ‘East to West’ strategy to expand CAR-T access across Australia and SE Asia
4M ago
1AD
AdAlta Completes Share and Option Issue to Sophisticated Investors
PremiumCompany Announcements
AdAlta Completes Share and Option Issue to Sophisticated Investors
4M ago
1AD
AdAlta Seeks ASX Quotation for New Shares and Options
PremiumCompany AnnouncementsAdAlta Seeks ASX Quotation for New Shares and Options
4M ago
1AD
AdAlta Seeks ASX Quotation for 240m New Shares and 120m Options
Premium
Company Announcements
AdAlta Seeks ASX Quotation for 240m New Shares and 120m Options
4M ago
1AD
AdAlta’s AdCella Gains Tailwind from FDA Shift as BZDS1901 Milestone and R&D Rebate Strengthen ‘East to West’ Strategy
Premium
Company Announcements
AdAlta’s AdCella Gains Tailwind from FDA Shift as BZDS1901 Milestone and R&D Rebate Strengthen ‘East to West’ Strategy
4M ago
1AD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >